Research
Metabolic adaptation
Metabolic syndrome prevalence dropped from 21.6% at baseline to 0% by week 52.
Achieving a normal BMI may eliminate metabolic syndrome risk in individuals.
StrongSupportsmedium confidence
Metabolic syndrome dropped from 21.6% at baseline to 0%.
Why this rating
Based on the post hoc analysis of a clinical trial.
Source
Association of tirzepatide with cardiometabolic benefits in Chinese adults: post hoc subgroup analysis of <scp>SURMOUNT</scp>‐<scp>CN</scp> study
Lin Zhao et al. · Obesity · 2025
other · n=177Cited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →